Hepatic Cell News Volume 6.19 | May 27 20220

    0
    17







    2022-05-27 | HCN 6.19


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.19 – 27 May, 2022
    TOP STORY

    Development of Human Pluripotent Stem Cell-Derived Hepatic Organoids as an Alternative Model for Drug Safety Assessment

    Researchers generated human pluripotent stem cell (hPSC)-derived hepatic organoids (hHOs) with a high drug metabolic ability. They established a two-step protocol to produce hHOs from human pluripotent stem cells for long-term expansion and drug testing.
    [Biomaterials]

    Full Article
    ON987CXN-jun-728x90-2022
    PUBLICATIONSRanked by the impact factor of the journal

    Targeting TROY-Mediated P85a/AKT/TBX3 Signaling Attenuates Tumor Stemness and Elevates Treatment Response in Hepatocellular Carcinoma

    Bioinformatics analysis of the TCGA dataset wasused to identify the function and mechanism of TROY. Spheroid, apoptosis, and ALDH assay were performed to evaluate the stemness functions.
    [Journal of Experimental & Clinical Cancer Research]

    Full ArticleGraphical Abstract

    Cancer Associated Fibroblast–Derived CCL5 Promotes Hepatocellular Carcinoma Metastasis through Activating HIF1α/ZEB1 Axis

    Scientists identified a mechanism by which cancer-associated fibroblasts-derived chemokine CCL5 enhanced HCC metastasis by triggering the HIF1α/ZEB1 axis.
    [Cell Death & Disease]

    Full Article

    Modeling Immune Cytotoxicity for Cholangiocarcinoma with Tumor-Derived Organoids and Effector T Cells

    Investigators developed a co-culture method with patient-derived cholangiocarcinoma organoids and immune cells, which could represent anti-cancer immunity in vitro.
    [British Journal of Cancer]

    Full Article

    Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis

    HepG2-TRβ cells were treated with bovine serum albumin-conjugated palmitic acid to mimic lipotoxic conditions in vitro.
    [Thyroid]

    Abstract

    Excess Fructose Enhances Oleatic Cytotoxicity via Reactive Oxygen Species Production and Causes Necroptosis in Hepatocytes

    The authors analyzed the hepatotoxicity of fructose in steatosis. Fructose effects on lipotoxicity were evaluated in HepG2 cells, primary mouse hepatocytes, and in mice fed a high-fat diet with or without sucrose.
    [Journal of Nutritional Biochemistry]

    Abstract

    Sorafenib and Nitazoxanide Disrupt Mitochondrial Function and Inhibit Regrowth Capacity in Three-Dimensional Models of Hepatocellular and Colorectal Carcinoma

    Cells grown in 3D cultures were sensitive to the oxidative phosphorylation inhibitor nitazoxanide, sorafenib, and regorafenib and resistant to other multikinase inhibitors and chemotherapeutic drugs.
    [Scientific Reports]

    Full Article

    IRF2BP2 Is a Novel HNF4α Co-Repressor: Its Role in Gluconeogenic Gene Regulation via Biochemically Labile Interaction

    Scientists applied novel proteomic techniques to evaluate the interactions of hepatocyte nuclear factor 4α (HNF4α), including those with biochemically labile binding proteins.
    [Biochemical and Biophysical Research Communications]

    Abstract

    Evaluating Nanobiomaterial-Induced DNA Strand Breaks Using the Alkaline Comet Assay

    The authors assessed five different nanobiomaterials (NBMd) formulations, including a bio-persistent gold nanoparticle, an IR-780 dye-loaded liposome which is used in deep tissue imaging, an unloaded PACA polymeric nanoparticle used as a drug delivery system (PACA) polymeric nanoparticle used as a drug delivery system, and two loaded PACA NBMs.
    [Drug Delivery and Translational Research]

    Full ArticleGraphical Abstract
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSRâ„¢ Plus.
    REVIEWS

    Roles of Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Non-Neoplastic Liver Diseases

    Scientists review recent findings on the roles of yes-associated protein and PDZ-binding motif in non-neoplastic liver diseases and discuss directions for future research.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    Indonesian Consensus on Systemic Therapies for Hepatocellular Carcinoma

    Numerous advances in systemic therapies have emerged in the last five years to fulfill the unmet needs of effective therapeutic options.
    [Asia-Pacific Journal of Clinical Oncology]

    Abstract
    INDUSTRY AND POLICY NEWS

    With the Right Partner, Pfizer Gains Fast-Track Tag for Previously Shelved NASH Drug

    In a rare win for the difficult field of nonalcoholic steatohepatitis (NASH) drug development, Pfizer has been granted a fast-track ticket for two experimental therapies.
    [Fierce Biotech]

    Press Release
    FEATURED EVENT

    European Association for Cancer Research (EACR) 2022: Innovative Cancer Science

    June 20 – 23, 2022
    Seville, Spain

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Lung and Liver Cancers

    Memorial Sloan Kettering Cancer Center – New York, New York, United States

    Staff Scientist – Obesity and Metabolic Diseases

    National Institutes of Health – Bethesda, Maryland, United States

    Postdoctoral Researcher – Bioinformatics

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Postdoctoral Scholarship – Medicinal Chemistry

    University of Gothenburg – Gothenburg, Sweden

    Postdoctoral Position – Viral Hepatitis

    National Institute for Health and Medical Research – Strasbourg, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter